COPANLISIB (BAY80-6946) Drug-drug Interaction and Cardiovascular Safety Study in Advanced Solid Tumor and Non-Hodgkin's Lymphoma Patients

NCT02253420 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

51

Enrollment

INDUSTRY

Sponsor class

Conditions

Medical Oncology

Interventions

DRUG: Copanlisib (BAY80-6946)
DRUG: Itraconazole
DRUG: Rifampin
DRUG: Copanlisib (BAY80-6946)

Sponsor

Bayer